Trade Delcath Systems, Inc. - DCTH CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.04 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004012% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 2.85 |
Open* | 2.81 |
1-Year Change* | -3.77% |
Day's Range* | 2.72 - 2.85 |
52 wk Range | 2.25-7.99 |
Average Volume (10 days) | 668.87K |
Average Volume (3 months) | 8.67M |
Market Cap | 65.26M |
P/E Ratio | -100.00K |
Shares Outstanding | 22.05M |
Revenue | 2.17M |
EPS | -3.52 |
Dividend (Yield %) | N/A |
Beta | 0.51 |
Next Earnings Date | Mar 25, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 1, 2023 | 2.85 | 0.15 | 5.56% | 2.70 | 2.88 | 2.68 |
Nov 30, 2023 | 2.72 | -0.04 | -1.45% | 2.76 | 2.88 | 2.70 |
Nov 29, 2023 | 2.78 | -0.08 | -2.80% | 2.86 | 2.91 | 2.78 |
Nov 28, 2023 | 2.83 | -0.14 | -4.71% | 2.97 | 2.97 | 2.79 |
Nov 27, 2023 | 2.96 | 0.02 | 0.68% | 2.94 | 3.10 | 2.93 |
Nov 24, 2023 | 2.98 | 0.11 | 3.83% | 2.87 | 2.99 | 2.84 |
Nov 22, 2023 | 2.88 | -0.11 | -3.68% | 2.99 | 3.07 | 2.85 |
Nov 21, 2023 | 2.95 | 0.03 | 1.03% | 2.92 | 3.03 | 2.71 |
Nov 20, 2023 | 2.67 | 0.19 | 7.66% | 2.48 | 2.83 | 2.44 |
Nov 17, 2023 | 2.42 | -0.05 | -2.02% | 2.47 | 2.52 | 2.36 |
Nov 16, 2023 | 2.46 | 0.10 | 4.24% | 2.36 | 2.50 | 2.35 |
Nov 15, 2023 | 2.37 | 0.08 | 3.49% | 2.29 | 2.59 | 2.29 |
Nov 14, 2023 | 2.30 | -0.60 | -20.69% | 2.90 | 2.95 | 2.30 |
Nov 13, 2023 | 2.96 | 0.09 | 3.14% | 2.87 | 3.03 | 2.87 |
Nov 10, 2023 | 2.93 | -0.01 | -0.34% | 2.94 | 3.00 | 2.86 |
Nov 9, 2023 | 2.97 | -0.13 | -4.19% | 3.10 | 3.12 | 2.89 |
Nov 8, 2023 | 3.13 | -0.07 | -2.19% | 3.20 | 3.25 | 3.10 |
Nov 7, 2023 | 3.22 | 0.03 | 0.94% | 3.19 | 3.27 | 3.10 |
Nov 6, 2023 | 3.17 | 0.10 | 3.26% | 3.07 | 3.25 | 3.07 |
Nov 3, 2023 | 3.11 | -0.09 | -2.81% | 3.20 | 3.30 | 3.01 |
Delcath Systems, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, March 25, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q4 2023 Delcath Systems Inc Earnings Release Q4 2023 Delcath Systems Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 2.719 | 3.555 | 1.646 | 1.58 | 3.407 |
Revenue | 2.719 | 3.555 | 1.646 | 1.58 | 3.407 |
Cost of Revenue, Total | 0.686 | 0.671 | 0.64 | 0.719 | 1.009 |
Gross Profit | 2.033 | 2.884 | 1.006 | 0.861 | 2.398 |
Total Operating Expense | 36.572 | 28.086 | 22.949 | 21.488 | 31.601 |
Selling/General/Admin. Expenses, Total | 16.103 | 13.637 | 11.108 | 11.279 | 9.819 |
Research & Development | 18.583 | 13.778 | 11.201 | 9.49 | 19.65 |
Operating Income | -33.853 | -24.531 | -21.303 | -19.908 | -28.194 |
Interest Income (Expense), Net Non-Operating | -2.685 | -1.186 | -3.007 | 11.027 | 8.921 |
Other, Net | 0.03 | 0.068 | 0.154 | 0.002 | 0.051 |
Net Income Before Taxes | -36.508 | -25.649 | -24.156 | -8.879 | -19.222 |
Net Income After Taxes | -36.508 | -25.649 | -24.156 | -8.879 | -19.222 |
Net Income Before Extra. Items | -36.508 | -25.649 | -24.156 | -8.879 | -19.222 |
Net Income | -36.508 | -25.649 | -24.156 | -8.879 | -19.222 |
Total Adjustments to Net Income | 0 | -0.055 | 0 | ||
Income Available to Common Excl. Extra. Items | -36.508 | -25.649 | -24.211 | -8.879 | -19.222 |
Income Available to Common Incl. Extra. Items | -36.508 | -25.649 | -24.211 | -8.879 | -19.222 |
Diluted Net Income | -36.508 | -25.649 | -24.211 | -8.879 | -19.222 |
Diluted Weighted Average Shares | 8.86462 | 7.14575 | 2.89783 | 0.0259 | 0.03819 |
Diluted EPS Excluding Extraordinary Items | -4.1184 | -3.5894 | -8.35488 | -342.819 | -503.343 |
Diluted Normalized EPS | -3.98303 | -3.5894 | -8.35488 | -342.819 | -473.936 |
Unusual Expense (Income) | 1.2 | 0 | 1.123 | ||
Total Extraordinary Items |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 0.495 | 0.597 | 0.639 | 0.906 | 0.797 |
Revenue | 0.495 | 0.597 | 0.639 | 0.906 | 0.797 |
Cost of Revenue, Total | 0.15 | 0.181 | 0.237 | 0.235 | 0.18 |
Gross Profit | 0.345 | 0.416 | 0.402 | 0.671 | 0.617 |
Total Operating Expense | 8.492 | 8.922 | 10.165 | 8.707 | 10.283 |
Selling/General/Admin. Expenses, Total | 4.787 | 4.165 | 4.994 | 3.319 | 4.497 |
Research & Development | 3.555 | 4.576 | 4.934 | 3.953 | 5.606 |
Operating Income | -7.997 | -8.325 | -9.526 | -7.801 | -9.486 |
Interest Income (Expense), Net Non-Operating | 0.789 | -0.688 | -0.645 | -0.73 | -0.665 |
Other, Net | 0.006 | 0.013 | 0.028 | 0.026 | -0.008 |
Net Income Before Taxes | -7.202 | -9 | -10.143 | -8.505 | -10.159 |
Net Income After Taxes | -7.202 | -9 | -10.143 | -8.505 | -10.159 |
Net Income Before Extra. Items | -7.202 | -9 | -10.143 | -8.505 | -10.159 |
Net Income | -7.202 | -9 | -10.143 | -8.505 | -10.159 |
Income Available to Common Excl. Extra. Items | -7.202 | -9 | -10.143 | -8.505 | -10.159 |
Income Available to Common Incl. Extra. Items | -7.202 | -9 | -10.143 | -8.505 | -10.159 |
Diluted Net Income | -7.202 | -9 | -10.143 | -8.505 | -10.159 |
Diluted Weighted Average Shares | 12.4637 | 11.6224 | 9.85044 | 9.21579 | 8.19048 |
Diluted EPS Excluding Extraordinary Items | -0.57784 | -0.77437 | -1.0297 | -0.92287 | -1.24034 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.57784 | -0.77437 | -1.0297 | -0.79266 | -1.24034 |
Total Adjustments to Net Income | |||||
Unusual Expense (Income) | 0 | 1.2 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 16.155 | 31.152 | 32.338 | 12.617 | 5.919 |
Cash and Short Term Investments | 7.671 | 22.802 | 28.575 | 10.002 | 2.516 |
Cash & Equivalents | 7.671 | 22.802 | 28.575 | 10.002 | 2.516 |
Total Receivables, Net | 0.366 | 0.044 | 0.057 | 0.021 | 1.164 |
Accounts Receivable - Trade, Net | 0.366 | 0.044 | 0.057 | 0.021 | 0.585 |
Total Inventory | 1.998 | 1.412 | 0.855 | 0.654 | 0.858 |
Other Current Assets, Total | 4.369 | 5.264 | 0.181 | 0.181 | 1.381 |
Total Assets | 17.862 | 33.124 | 34.635 | 14.212 | 6.844 |
Property/Plant/Equipment, Total - Net | 1.707 | 1.972 | 2.297 | 1.595 | 0.925 |
Property/Plant/Equipment, Total - Gross | 6.638 | 6.797 | 5.232 | ||
Accumulated Depreciation, Total | -4.931 | -4.825 | -4.307 | ||
Total Current Liabilities | 14.735 | 5.954 | 10.035 | 15.994 | 17.75 |
Accounts Payable | 2.018 | 0.638 | 1.774 | 4.533 | 7.715 |
Accrued Expenses | 4.871 | 3.974 | 5.736 | 7.611 | 3.434 |
Notes Payable/Short Term Debt | 0 | 0.551 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.846 | 0.621 | 2 | 0 | 2.038 |
Other Current Liabilities, Total | 0 | 0.17 | 0.525 | 3.85 | 4.563 |
Total Liabilities | 23.721 | 21.172 | 12.557 | 20.569 | 21.783 |
Total Long Term Debt | 7.842 | 15.011 | 0 | 2 | 0 |
Other Liabilities, Total | 1.144 | 0.207 | 2.522 | 2.575 | 4.033 |
Total Equity | -5.859 | 11.952 | 22.078 | -6.357 | -14.939 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.1 | 0.079 | 0.06 | 0.001 | 0.103 |
Additional Paid-In Capital | 451.608 | 432.831 | 417.449 | 364.785 | 328.962 |
Retained Earnings (Accumulated Deficit) | -457.484 | -420.976 | -395.327 | -371.171 | -344.054 |
Treasury Stock - Common | 0 | ||||
Other Equity, Total | -0.083 | 0.018 | -0.104 | 0.028 | 0.05 |
Total Liabilities & Shareholders’ Equity | 17.862 | 33.124 | 34.635 | 14.212 | 6.844 |
Total Common Shares Outstanding | 10.0466 | 7.90673 | 5.9961 | 0.06709 | 0.01463 |
Prepaid Expenses | 1.751 | 1.63 | 2.67 | 1.759 | |
Other Long Term Assets, Total | 0 | ||||
Long Term Debt | 7.842 | 15.011 | 0 | 2 | |
Total Preferred Shares Outstanding | 0.01136 | 0.01136 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 46.096 | 19.472 | 29.022 | 16.155 | 18.48 |
Cash and Short Term Investments | 40.462 | 14.54 | 24.222 | 7.671 | 9.831 |
Cash & Equivalents | 40.462 | 14.54 | 24.222 | 7.671 | 9.831 |
Total Receivables, Net | 0.205 | 0.127 | 0.458 | 0.366 | 0.537 |
Accounts Receivable - Trade, Net | 0.205 | 0.127 | 0.458 | 0.366 | 0.537 |
Total Inventory | 2.667 | 2.48 | 2.337 | 1.998 | 1.926 |
Prepaid Expenses | 2.285 | 2.019 | 1.721 | 1.751 | 1.84 |
Other Current Assets, Total | 0.477 | 0.306 | 0.284 | 4.369 | 4.346 |
Total Assets | 47.577 | 21.05 | 30.599 | 17.862 | 20.226 |
Property/Plant/Equipment, Total - Net | 1.481 | 1.578 | 1.577 | 1.707 | 1.746 |
Property/Plant/Equipment, Total - Gross | 6.498 | 6.577 | 6.547 | 6.638 | 6.609 |
Accumulated Depreciation, Total | -5.017 | -4.999 | -4.97 | -4.931 | -4.863 |
Total Current Liabilities | 13.974 | 11.114 | 13.411 | 14.735 | 14.446 |
Accounts Payable | 0.753 | 0.966 | 2.428 | 2.018 | 2.632 |
Accrued Expenses | 5.265 | 5.638 | 7.213 | 4.871 | 5.333 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.956 | 4.51 | 3.77 | 7.846 | 6.481 |
Other Current Liabilities, Total | 0 | 0 | |||
Total Liabilities | 22.858 | 21.292 | 25.307 | 23.721 | 25.472 |
Total Long Term Debt | 2 | 5.252 | 5.798 | 7.842 | 9.727 |
Other Liabilities, Total | 6.884 | 4.926 | 6.098 | 1.144 | 1.299 |
Total Equity | 24.719 | -0.242 | 5.292 | -5.859 | -5.246 |
Common Stock | 0.197 | 0.153 | 0.101 | 0.1 | 0.086 |
Additional Paid-In Capital | 518.607 | 473.355 | 453.37 | 451.608 | 442.066 |
Retained Earnings (Accumulated Deficit) | -494.026 | -473.686 | -466.483 | -457.484 | -447.341 |
Other Equity, Total | -0.059 | -0.064 | -0.064 | -0.083 | -0.057 |
Total Liabilities & Shareholders’ Equity | 47.577 | 21.05 | 30.599 | 17.862 | 20.226 |
Total Common Shares Outstanding | 19.689 | 15.2505 | 10.0816 | 10.0466 | 8.59768 |
Long Term Debt | 2 | 5.252 | 5.798 | 7.842 | 9.727 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 18.368 | 0 | 0 |
Total Preferred Shares Outstanding | 0.03779 | 0.02098 | 0.01136 | 0.01136 | 0.01136 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -36.508 | -25.649 | -24.156 | -8.879 | -19.222 |
Cash From Operating Activities | -24.95 | -22.604 | -22.868 | -23.69 | -14.732 |
Cash From Operating Activities | 0.132 | 0.146 | 0.167 | 0.212 | 0.444 |
Non-Cash Items | 9.312 | 8.663 | 6.927 | -7.92 | -7.726 |
Changes in Working Capital | 2.114 | -5.764 | -5.806 | -7.103 | 11.772 |
Cash From Investing Activities | -0.209 | -0.143 | -0.782 | -0.024 | -0.076 |
Capital Expenditures | -0.209 | -0.143 | -0.782 | -0.024 | -0.076 |
Other Investing Cash Flow Items, Total | |||||
Cash From Financing Activities | 10.143 | 20.822 | 42.355 | 30.305 | 13.236 |
Financing Cash Flow Items | 0 | -0.107 | 26.475 | 0 | |
Issuance (Retirement) of Stock, Net | 10.857 | 6.385 | 42.488 | 0.15 | 12.442 |
Issuance (Retirement) of Debt, Net | -0.714 | 14.437 | -0.026 | 3.68 | 0.794 |
Foreign Exchange Effects | -0.115 | 0.122 | -0.132 | 0.014 | -0.174 |
Net Change in Cash | -15.131 | -1.803 | 18.573 | 6.605 | -1.746 |
Cash Interest Paid | 1.873 | 0.681 | 0.011 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -9 | -36.508 | -26.365 | -17.86 | -8.203 |
Cash From Operating Activities | -4.264 | -24.95 | -17.591 | -12.412 | -6.375 |
Cash From Operating Activities | 0.03 | 0.132 | 0.098 | 0.031 | 0.031 |
Non-Cash Items | 1.982 | 9.312 | 5.378 | 3.785 | 1.805 |
Cash Interest Paid | 0.491 | 1.873 | 1.337 | 0.842 | 0.411 |
Changes in Working Capital | 2.724 | 2.114 | 3.298 | 1.632 | -0.008 |
Cash From Investing Activities | 0 | -0.209 | -0.209 | -0.141 | -0.089 |
Capital Expenditures | 0 | -0.209 | -0.209 | -0.141 | -0.089 |
Cash From Financing Activities | 16.694 | 10.143 | 4.896 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 23.007 | 10.857 | 4.896 | 0 | 0 |
Issuance (Retirement) of Debt, Net | -6.313 | -0.714 | 0 | ||
Foreign Exchange Effects | 0.02 | -0.115 | -0.067 | -0.046 | 0.002 |
Net Change in Cash | 12.45 | -15.131 | -12.971 | -12.599 | -6.462 |
Financing Cash Flow Items |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Vivo Capital, LLC | Venture Capital | 7.7163 | 1178787 | 1178787 | 2023-06-30 | LOW |
BVF Partners L.P. | Hedge Fund | 7.7163 | 1178787 | 1178787 | 2023-06-30 | LOW |
Logos Global Management LLC | Investment Advisor | 7.7163 | 1178787 | 1178787 | 2023-06-30 | HIGH |
Soleus Capital Management, L.P. | Hedge Fund | 5.2788 | 806420 | 806420 | 2023-08-15 | HIGH |
Rosalind Advisors, Inc. | Hedge Fund | 3.0067 | 459315 | 59315 | 2022-12-21 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.545 | 388789 | 18463 | 2023-06-30 | LOW |
Stonepine Capital Management, LLC | Investment Advisor/Hedge Fund | 2.4795 | 378787 | 378787 | 2023-06-30 | HIGH |
Michel (Gerard J) | Individual Investor | 1.4947 | 228345 | 31110 | 2023-08-18 | LOW |
Kent Lake Capital LLC | Hedge Fund | 1.4366 | 219468 | 0 | 2023-06-30 | HIGH |
EAM Investors, LLC | Investment Advisor/Hedge Fund | 1.0165 | 155280 | 155280 | 2023-06-30 | HIGH |
CIBC World Markets Inc. | Research Firm | 0.8164 | 124717 | 21885 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7628 | 116536 | 53803 | 2023-06-30 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.3988 | 60926 | 17115 | 2023-06-30 | LOW |
Salamon (Steven A. J.) | Individual Investor | 0.3621 | 55315 | 0 | 2023-04-20 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2992 | 45703 | 30178 | 2023-06-30 | LOW |
Purpura (John) | Individual Investor | 0.2718 | 41526 | 14505 | 2023-10-13 | LOW |
Advisors Capital Management, LLC | Investment Advisor | 0.1769 | 27021 | 0 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1752 | 26757 | 0 | 2023-06-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.1407 | 21500 | 9400 | 2023-06-30 | HIGH |
Citadel Advisors LLC | Hedge Fund | 0.1203 | 18373 | 18373 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Delcath Systems, Inc. Company profile
About Delcath Systems Inc
Delcath Systems, Inc. is an oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company is a specialty pharmaceutical and medical device company developing its products. The Company's lead product candidate is HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Delcath Systems Inc revenues increased 27% to $1.4M. Net loss applicable to common stockholders increased 18% to $20.3M. Revenues reflect Product revenue increase of 35% to $1.1M, Other revenue increase of 9% to $392K. Higher net loss reflects Research and development expenses increase from $3M to $8.3M (expense), Stock-based Compensation in SGA increase from $49K to $4.2M (expense), Selling.
Equity composition
Common Stock $.01 Par, 12/10, 70M auth., 43,028,146 issd., less 28,100 shares in Treas. @ $51.1M. Insiders control 1.42%. InitialPublic Offering 10/20/00, 1.2M Units (1 Common+ 1Redeemable Warrant) @ $6 by Whale Securities Co . 5/20/03,Company sold 677,419 Units (5 Common + 5 Warrants) @ $3.10/unit. 98.3. 04/14, 1-for-16 Reverse stock split.
Industry: | Medical Prosthetics |
1633 Broadway Ste 22C
NEW YORK
NEW YORK 10019-6708
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com